Thrombosis and dyslipidemia.
- Published in:
- Formulary, 2004, v. 39, n. 9, p. 464
- Publication type:
- Article
Works matching IS 1082801X AND DT 2004 AND VI 39 AND IP 9
Results: 21
1
2
Ezetimibe/simvastatin: a combination product for the treatment of hyperlipidemia.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
3
STATE-BY-STATE IN BRIEF.
- Published in:
- Formulary, 2004, v. 39, n. 9, p. 462
- Publication type:
- Article
4
National patient safety database would track medical errors.
- Published in:
- Formulary, 2004, v. 39, n. 9, p. 461
- Publication type:
- Article
5
Lack of regulatory resources implicated for surge In unapproved drug imports.
- Published in:
- Formulary, 2004, v. 39, n. 9, p. 461
- Publication type:
- Article
6
FDA revises drug review nomenclature, process.
- Published in:
- Formulary, 2004, v. 39, n. 9, p. 461
- Publication type:
- Article
7
Vermont files suit against FDA challenging importation decision.
- Published in:
- Formulary, 2004, v. 39, n. 9, p. 458
- Publication type:
- Article
8
'Critical Path' for drug development a priority.
- Published in:
- Formulary, 2004, v. 39, n. 9, p. 458
- Publication type:
- Article
9
Medicare Model Guideline in development for drug classes/categories.
- Published in:
- Formulary, 2004, v. 39, n. 9, p. 458
- Publication type:
- Article
10
Drug-eluting stents: A pharmacy management perspective.
- Published in:
- Formulary, 2004, v. 39, n. 9, p. 446
- By:
- Publication type:
- Article
11
Ezetimibe/simvastatin.
- Published in:
- Formulary, 2004, v. 39, n. 9, p. 437
- By:
- Publication type:
- Article
12
Study evaluates aspirin comedication rates among long-term COX-2 inhibitor users.
- Published in:
- Formulary, 2004, v. 39, n. 9, p. 434
- Publication type:
- Article
13
FDA actions in brief.
- Published in:
- Formulary, 2004, v. 39, n. 9, p. 431
- Publication type:
- Article
14
Higher-dose rofecoxib linked to 3x greater risk of acute cardiac events compared to other NSAIDs.
- Published in:
- Formulary, 2004, v. 39, n. 9, p. 433
- Publication type:
- Article
15
Liraglutide effective in treating type 2 diabetes.
- Published in:
- Formulary, 2004, v. 39, n. 9, p. 432
- Publication type:
- Article
16
Aspirin, warfarin may lack heart failure benefits.
- Published in:
- Formulary, 2004, v. 39, n. 9, p. 433
- Publication type:
- Article
17
New indications.
- Published in:
- Formulary, 2004, v. 39, n. 9, p. 428
- Publication type:
- Article
18
Atorvastatin associated with modest but clinically apparent improvement in RA symptoms.
- Published in:
- Formulary, 2004, v. 39, n. 9, p. 432
- Publication type:
- Article
19
First-time generic approvals.
- Published in:
- Formulary, 2004, v. 39, n. 9, p. 431
- Publication type:
- Article
20
New molecular entities.
- Published in:
- Formulary, 2004, v. 39, n. 9, p. 428
- Publication type:
- Article
21
Pipeline preview.
- Published in:
- Formulary, 2004, v. 39, n. 9, p. 428
- Publication type:
- Article